Table 4. Scenario sensitivity analysis.
Scenario | Rotarix | RotaTeq |
Base case | $142 | $288 |
No discounting | $139 | $283 |
Ignore community mortality | $1,688 | $3,414 |
Ignore costs | $178 | $342 |
High incidence outpatient (23,974 per 100,000) | Cost saving | $66 |
Protection after first year 50% of the vaccine efficacy | $100 | $210 |
Protection after first year 100% of the vaccine efficacy | $75 | $163 |
% diarrhoea death due to Rotavirus 15.5% (as in the outpatient); incidence 35 per 100,000 | $262 | $535 |
% diarrhoea deaths due to Rotavirus 42,5% (as in Kenyatta national hospital); incidence 98 per 100,000 | $94 | $191 |
10% lower vaccine efficacy for all outcomes (47,5%/66,9%) | $170 | $338 |
20% lower vaccine efficacy for all outcomes (37,5%/56,9%) | $209 | $406 |
Outcome in the cost per DALY for various scenarios. For each scenario the median Cost per DALY are shown (societal perspective).